• 3559 Citations
  • 32 h-Index
1990 …2019
If you made any changes in Pure these will be visible here soon.

Personal profile

Personal profile

Personal profile

7 ~

한국분자세포생물학회 부회장

2016 ~

연세대학교 언더우드특훈교수

2014 ~ 2015

한국세포생물학회 회장

2009 ~

단백질기능제어이행연구센터 소장

2005 ~

국가지정연구실 분자복합체 기능제어연구실 책임자

2004 ~

연세대학교 생명시스템대학 생명공학과 교수

2001 ~ 2004

연세대학교 생명시스템대학 생명공학과 부교수

2000 ~ 2001

연세대학교 의과대학 생화학분자생물학 부교수

1995 ~ 2000

연세대학교 의과대학 생화학분자생물학 조교수

1993 ~ 1995

미국 하버드대학교 의과대학 생화학분자약리학과 박사후 연구원

Fingerprint Dive into the research topics where Kang-Yell Choi is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 14 Similar Profiles
Catenins Medicine & Life Sciences
Wnt Signaling Pathway Medicine & Life Sciences
Extracellular Signal-Regulated MAP Kinases Medicine & Life Sciences
Colorectal Neoplasms Medicine & Life Sciences
MAP Kinase Signaling System Medicine & Life Sciences
Cells Chemical Compounds
Mitogen-Activated Protein Kinases Medicine & Life Sciences
Proteins Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1990 2019

3 Citations (Scopus)

A Ras destabilizer KYA1797K overcomes the resistance of EGFR tyrosine kinase inhibitor in KRAS-mutated non-small cell lung cancer

Park, J., Cho, Y. H., Shin, W. J., Lee, S. K., Lee, J. H., Kim, T., Cha, P. H., Yang, J. S., Cho, J., Min, D. S., Han, G., Lee, H. Y. & Choi, K-Y., 2019 Dec 1, In : Scientific reports. 9, 1, 648.

Research output: Contribution to journalArticle

Epidermal Growth Factor Receptor
Non-Small Cell Lung Carcinoma
Protein-Tyrosine Kinases
Wnt Signaling Pathway

A therapeutic strategy for chemotherapy-resistant gastric cancer via destabilization of both β-catenin and ras

Ryu, W. J., Lee, J. E., Cho, Y. H., Lee, G., Seo, M. K., Lee, S. K., Hwang, J. H., Min, D. S., Noh, S. H., Paik, S., Kim, S., Cheong, J. H. & Choi, K-Y., 2019 Apr 1, In : Cancers. 11, 4, 496.

Research output: Contribution to journalArticle

Open Access
Stomach Neoplasms
Drug Therapy

CXXC5 mediates growth plate senescence and is a target for enhancement of longitudinal bone growth

Choi, S., Kim, H. Y., Cha, P. H., Seo, S. H., Lee, C., Choi, Y., Shin, W., Heo, Y., Han, G., Lee, W. T. & Choi, K-Y., 2019 Jan 1, In : Life Science Alliance. 2, 2, e201800254.

Research output: Contribution to journalArticle

Open Access
growth plate
Growth Plate
Bone Development

WDR76 is a RAS binding protein that functions as a tumor suppressor via RAS degradation

Jeong, W. J., Park, J. C., Kim, W. S., Ro, E. J., Jeon, S. H., Lee, S. K., Park, Y. N., Min, D. S. & Choi, K-Y., 2019 Dec 1, In : Nature communications. 10, 1, 295.

Research output: Contribution to journalArticle

Carrier Proteins

A small molecule approach to degrade RAS with EGFR repression is a potential therapy for KRAS mutation-driven colorectal cancer resistance to cetuximab

Lee, S. K., Cho, Y. H., Cha, P. H., Yoon, J. S., Ro, E. J., Jeong, W. J., Park, J., Kim, H., Il Kim, T., Min, D. S., Han, G. & Choi, K-Y., 2018 Nov 1, In : Experimental and Molecular Medicine. 50, 11, 153.

Research output: Contribution to journalArticle

Epidermal Growth Factor Receptor
Colorectal Neoplasms

Press / Media

Wait. Did South Korea just cure baldness

Kang-Yell Choi


1 item of media coverage

Press/Media: Press / Media

Do you know? - December 2017

Kang-Yell Choi


1 item of media coverage

Press/Media: Press / Media